These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31740053)

  • 21. Synthesis, biological and molecular dynamics investigations with a series of triazolopyrimidine/triazole-based benzenesulfonamides as novel carbonic anhydrase inhibitors.
    Said MA; Eldehna WM; Nocentini A; Bonardi A; Fahim SH; Bua S; Soliman DH; Abdel-Aziz HA; Gratteri P; Abou-Seri SM; Supuran CT
    Eur J Med Chem; 2020 Jan; 185():111843. PubMed ID: 31718943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinetic and X-ray crystallographic investigations on carbonic anhydrase isoforms I, II, IX and XII of a thioureido analog of SLC-0111.
    Lomelino CL; Mahon BP; McKenna R; Carta F; Supuran CT
    Bioorg Med Chem; 2016 Mar; 24(5):976-81. PubMed ID: 26810836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis and biochemical evaluation of novel carbonic anhydrase inhibitors triggered by structural knowledge on hCA VII.
    Mancuso F; Di Fiore A; De Luca L; Angeli A; De Simone G; Supuran CT; Gitto R
    Bioorg Med Chem; 2021 Aug; 44():116279. PubMed ID: 34216985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis and biological evaluation of N-(5-methyl-isoxazol-3-yl/1,3,4-thiadiazol-2-yl)-4-(3-substitutedphenylureido) benzenesulfonamides as human carbonic anhydrase isoenzymes I, II, VII and XII inhibitors.
    Mishra CB; Kumari S; Angeli A; Monti SM; Buonanno M; Prakash A; Tiwari M; Supuran CT
    J Enzyme Inhib Med Chem; 2016; 31(sup2):174-179. PubMed ID: 27314170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New 4-[(3-cyclohexyl-4-aryl-2,3-dihydro-1,3-thiazol-2-ylidene)amino]benzene-1-sulfonamides, synthesis and inhibitory activity toward carbonic anhydrase I, II, IX, XII.
    Meleddu R; Maccioni E; Distinto S; Bianco G; Melis C; Alcaro S; Cottiglia F; Ceruso M; Supuran CT
    Bioorg Med Chem Lett; 2015 Aug; 25(16):3281-4. PubMed ID: 26073006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and carbonic anhydrase I, II, VII, and IX inhibition studies with a series of benzo[d]thiazole-5- and 6-sulfonamides.
    Abdoli M; Angeli A; Bozdag M; Carta F; Kakanejadifard A; Saeidian H; Supuran CT
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1071-1078. PubMed ID: 28753093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 4-[N-(substituted 4-pyrimidinyl)amino]benzenesulfonamides as inhibitors of carbonic anhydrase isozymes I, II, VII, and XIII.
    Sūdžius J; Baranauskienė L; Golovenko D; Matulienė J; Michailovienė V; Torresan J; Jachno J; Sukackaitė R; Manakova E; Gražulis S; Tumkevičius S; Matulis D
    Bioorg Med Chem; 2010 Nov; 18(21):7413-21. PubMed ID: 20889345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel benzenesulfonamides aryl and arylsulfone conjugates adopting tail/dual tail approaches: Synthesis, carbonic anhydrase inhibitory activity and molecular modeling studies.
    Eldeeb AH; Abo-Ashour MF; Angeli A; Bonardi A; Lasheen DS; Elrazaz EZ; Nocentini A; Gratteri P; Abdel-Aziz HA; Supuran CT
    Eur J Med Chem; 2021 Oct; 221():113486. PubMed ID: 33965860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural study of the location of the phenyl tail of benzene sulfonamides and the effect on human carbonic anhydrase inhibition.
    Güzel-Akdemir O; Biswas S; Lastra K; McKenna R; Supuran CT
    Bioorg Med Chem; 2013 Nov; 21(21):6674-80. PubMed ID: 24012377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozymes I and II and tumor-associated isozymes IX and XII with S-substituted 4-chloro-2-mercapto-5-methyl-benzenesulfonamides.
    Saczewski F; Innocenti A; Sławiński J; Kornicka A; Brzozowski Z; Pomarnacka E; Scozzafava A; Temperini C; Supuran CT
    Bioorg Med Chem; 2008 Apr; 16(7):3933-40. PubMed ID: 18242998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conformational variability of different sulfonamide inhibitors with thienyl-acetamido moieties attributes to differential binding in the active site of cytosolic human carbonic anhydrase isoforms.
    Biswas S; Aggarwal M; Güzel Ö; Scozzafava A; McKenna R; Supuran CT
    Bioorg Med Chem; 2011 Jun; 19(12):3732-8. PubMed ID: 21620713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbonic anhydrase inhibitors: X-ray crystal structure of a benzenesulfonamide strong CA II and CA IX inhibitor bearing a pentafluorophenylaminothioureido tail in complex with isozyme II.
    Di Fiore A; De Simone G; Menchise V; Pedone C; Casini A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Apr; 15(7):1937-42. PubMed ID: 15780637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual-tail arylsulfone-based benzenesulfonamides differently match the hydrophobic and hydrophilic halves of human carbonic anhydrases active sites: Selective inhibitors for the tumor-associated hCA IX isoform.
    Ibrahim HS; Allam HA; Mahmoud WR; Bonardi A; Nocentini A; Gratteri P; Ibrahim ES; Abdel-Aziz HA; Supuran CT
    Eur J Med Chem; 2018 May; 152():1-9. PubMed ID: 29684705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis 4-[2-(2-mercapto-4-oxo-4H-quinazolin-3-yl)-ethyl]-benzenesulfonamides with subnanomolar carbonic anhydrase II and XII inhibitory properties.
    Bozdag M; Alafeefy AM; Carta F; Ceruso M; Al-Tamimi AS; Al-Kahtani AA; Alasmary FAS; Supuran CT
    Bioorg Med Chem; 2016 Sep; 24(18):4100-4107. PubMed ID: 27396930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benzenesulfonamide bearing 1,2,4-triazole scaffolds as potent inhibitors of tumor associated carbonic anhydrase isoforms hCA IX and hCA XII.
    SitaRam ; Celik G; Khloya P; Vullo D; Supuran CT; Sharma PK
    Bioorg Med Chem; 2014 Mar; 22(6):1873-82. PubMed ID: 24560737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbonic anhydrase inhibitors: Design, synthesis and structural characterization of new heteroaryl-N-carbonylbenzenesulfonamides targeting druggable human carbonic anhydrase isoforms.
    Buemi MR; De Luca L; Ferro S; Bruno E; Ceruso M; Supuran CT; Pospíšilová K; Brynda J; Řezáčová P; Gitto R
    Eur J Med Chem; 2015 Sep; 102():223-32. PubMed ID: 26276436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: Solution and X-ray crystallographic studies.
    Carta F; Garaj V; Maresca A; Wagner J; Avvaru BS; Robbins AH; Scozzafava A; McKenna R; Supuran CT
    Bioorg Med Chem; 2011 May; 19(10):3105-19. PubMed ID: 21515057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5-Substituted-(1,2,3-triazol-4-yl)thiophene-2-sulfonamides strongly inhibit human carbonic anhydrases I, II, IX and XII: solution and X-ray crystallographic studies.
    Leitans J; Sprudza A; Tanc M; Vozny I; Zalubovskis R; Tars K; Supuran CT
    Bioorg Med Chem; 2013 Sep; 21(17):5130-8. PubMed ID: 23859774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isoform-selective inhibitory profile of 2-imidazoline-substituted benzene sulfonamides against a panel of human carbonic anhydrases.
    Supuran CT; Kalinin S; Tanç M; Sarnpitak P; Mujumdar P; Poulsen SA; Krasavin M
    J Enzyme Inhib Med Chem; 2016; 31(sup1):197-202. PubMed ID: 27160030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel 2-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)-1-(1,3,5-triazin-2-ylamino)guanidine derivatives: Inhibition of human carbonic anhydrase cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII, anticancer activity, and molecular modeling studies.
    Żołnowska B; Sławiński J; Szafrański K; Angeli A; Supuran CT; Kawiak A; Wieczór M; Zielińska J; Bączek T; Bartoszewska S
    Eur J Med Chem; 2018 Jan; 143():1931-1941. PubMed ID: 29146134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.